logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-4. Demographic characteristics of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (i) New clients by country and gender (%)

CountryYear%%Gender GenderGender
MaleFemaleratioknown (n)unknown
Belgium20097921431962
Bulgaria2009831753694
Czech Republic200967332430314
Denmark20097624318270
Germany200982185155700
Estonia2009732731570
Ireland20098020434255
Greece20098614626030
Spain(1)2008841652285688
France200984165108440
Italy200985156339830
Cyprus2009861463190
Latvia2009792244740
Lithuania2009831753450
Luxembourg200962382210
Hungary20098812728386
Malta2009861462500
Netherlands20097723361960
Austria20097723320760
Poland(1)20087228363620
Portugal2009851657245398
Romania20097921410053
Slovenia2009802043710
Slovakia2009811948930
Finland2009683223030
Sweden200970302167717
United Kingdom200974263450480
Croatia20098020414630
Turkey200993714145624
Norway::::::
Total:80204177475561

Notes:

 : Indicates no data available 

 Percentages are of clients whose gender is known (n). 

 (1) Last data available refer to 2008. Data presented are from two different monitoring systems (Pilot project for TDI monitoring and Institute of Psychiatry and Neurology - aggregated data). Caution must be made when interpreting the data as double counting could not be avoid. 

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2010 — TDI tables V. 1.0-2010. See Table TDI-0 for details on sources.   

(see the help page for information about formats etc.)

Page last updated: Wednesday, 29 June 2011